Financials

Discussions Technicals Seasonals

T5O0 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

bioXXmed AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept. The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

T5O0 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company